Search by Drug Name or NDC

    NDC 70121-1003-01 Eptifibatide 0.75 mg/mL Details

    Eptifibatide 0.75 mg/mL

    Eptifibatide is a INTRAVENOUS INJECTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Amneal Pharmaceuticals LLC. The primary component is EPTIFIBATIDE.

    Product Information

    NDC 70121-1003
    Product ID 70121-1003_36507d1c-5ac6-470d-aa90-ae27f1c9cc0d
    Associated GPIs 85153030002010
    GCN Sequence Number 039891
    GCN Sequence Number Description eptifibatide VIAL 75MG/100ML INTRAVEN
    HIC3 M9P
    HIC3 Description PLATELET AGGREGATION INHIBITORS
    GCN 49151
    HICL Sequence Number 018422
    HICL Sequence Number Description EPTIFIBATIDE
    Brand/Generic Generic
    Proprietary Name Eptifibatide
    Proprietary Name Suffix n/a
    Non-Proprietary Name Eptifibatide
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form INJECTION
    Route INTRAVENOUS
    Active Ingredient Strength 0.75
    Active Ingredient Units mg/mL
    Substance Name EPTIFIBATIDE
    Labeler Name Amneal Pharmaceuticals LLC
    Pharmaceutical Class Decreased Platelet Aggregation [PE], Platelet Aggregation Inhibitor [EPC]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA205581
    Listing Certified Through 2024-12-31

    Package

    NDC 70121-1003-01 (70121100301)

    NDC Package Code 70121-1003-1
    Billing NDC 70121100301
    Package 1 VIAL, GLASS in 1 CARTON (70121-1003-1) / 100 mL in 1 VIAL, GLASS
    Marketing Start Date 2016-12-08
    NDC Exclude Flag N
    Pricing Information N/A